The study for clinical usefulness of the cross-linked N-telopeptide of type I collagen as a marker of denosumab treatment of bone metastasis from lung cancer
Not Applicable
- Conditions
- lung cancer with bone metastasis
- Registration Number
- JPRN-UMIN000013752
- Lead Sponsor
- Osaka prefectural Medical Center for Respiratory and Allergic Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1:Patient who judged that research representative or allotment researcher is improper 2:Bisphosphonate administering patient 3:Metabolic bone disease patient 4:Kidney function deterioration patient 5:treatment for lung cancer in the past
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1:Utility examination of NTX in monitor of therapeutic gain after bone metastasis is diagnosed and bone metastasis progress level 2:Utility of bone metastasis index
- Secondary Outcome Measures
Name Time Method